How to Get Testosterone Enanthate in Maryland

Who Can Prescribe Testosterone Enanthate in Maryland

Any Maryland-licensed physician (MD or DO), certified registered nurse practitioner (CRNP), or physician assistant (PA) with prescriptive authority can write a testosterone enanthate prescription. Maryland CRNPs gained independent practice authority under Senate Bill 601 (2015), which removed the requirement for a collaborative agreement with a physician. PAs still practice under a delegation agreement but retain Schedule III prescribing rights.

Board-certified endocrinologists and urologists prescribe testosterone enanthate most frequently, though primary care physicians handle the majority of ongoing TRT management in community settings. A 2020 cross-sectional analysis found that primary care providers wrote 48.7% of all testosterone prescriptions in the United States, compared to 12.1% by urologists and 4.3% by endocrinologists [1]. This pattern holds in Maryland, where roughly 6.2 million residents are served by fewer than 150 practicing endocrinologists.

If you already have an established diagnosis of hypogonadism from another state, a Maryland-licensed provider can review your records and continue therapy without repeating the full diagnostic workup. They will, however, need recent lab values. "Recent" generally means within the past 6 months.

Telehealth Access for Testosterone Enanthate in Maryland

Maryland permits telehealth prescribing of controlled substances, including Schedule III drugs like testosterone enanthate. The Ryan Haight Act requires that a valid prescriber-patient relationship exists before a controlled substance prescription is issued; Maryland meets this through synchronous audio-video encounters [2].

The Maryland Board of Physicians requires telehealth prescribers to hold an active, unrestricted Maryland medical license or multi-state compact privilege. Several national TRT telehealth platforms operate in Maryland, including HealthRX, which pairs patients with board-certified clinicians who specialize in hormone optimization.

A typical telehealth TRT pathway in Maryland looks like this: complete an intake questionnaire, get lab work drawn at a local lab (Quest Diagnostics and Labcorp both have extensive Maryland networks, with over 60 draw sites statewide), attend a video consultation, receive your prescription electronically, and have medication shipped or pick it up at a local pharmacy.

The Endocrine Society's 2018 clinical practice guideline recommends confirming hypogonadism with two morning total testosterone measurements below 300 ng/dL before initiating therapy [3]. Telehealth providers who follow evidence-based protocols will require this confirmation regardless of how convenient the platform is. Speed matters, but diagnostic rigor matters more.

Lab Requirements Before Starting TRT in Maryland

Maryland prescribers follow the same evidence-based lab protocols used nationally. The Endocrine Society guideline (2018) specifies the minimum diagnostic workup before testosterone therapy [3].

Required baseline labs:

• Total testosterone (drawn between 7:00 and 10:00 AM, fasting preferred)
• Confirmatory repeat total testosterone if the first value is low
• Complete blood count (CBC), with attention to hematocrit
• Comprehensive metabolic panel (CMP)
• Luteinizing hormone (LH) and follicle-stimulating hormone (FSH)
• Prostate-specific antigen (PSA) for men aged 40 and older
• Lipid panel

Additional labs depending on clinical context:

• Free testosterone (calculated or equilibrium dialysis)
• Sex hormone-binding globulin (SHBG)
• Prolactin (if testosterone is very low or secondary hypogonadism is suspected)
• Estradiol
• Thyroid panel

The T-Trials, a coordinated set of seven placebo-controlled studies enrolling 790 men aged 65 and older with testosterone levels below 275 ng/dL, demonstrated that testosterone gel treatment for one year improved sexual function, physical activity, and mood compared to placebo (NEJM 2016) [4]. These trials also reinforced the importance of baseline cardiovascular risk assessment. Hematocrit must be monitored because testosterone stimulates erythropoiesis; the Endocrine Society recommends checking hematocrit at 3 to 6 months and then annually, with a threshold of 54% triggering dose adjustment or phlebotomy [3].

Maryland Medicaid and Insurance Coverage

Maryland Medicaid covers testosterone enanthate for the FDA-approved indication of male hypogonadism, but a prior authorization (PA) is required. The PA process verifies that the patient has a documented diagnosis, confirmatory lab work, and no absolute contraindications.

Typical prior authorization documentation:

• Two morning total testosterone levels below 300 ng/dL
• ICD-10 diagnosis code (E29.1 for testicular hypofunction)
• Clinical notes documenting symptoms of hypogonadism
• Evidence that the prescriber evaluated contraindications: untreated polycythemia, untreated obstructive sleep apnea, uncontrolled heart failure, PSA above 4 ng/mL without urologic clearance, or desire for near-term fertility

Commercial insurers in Maryland (CareFirst BlueCross BlueShield, Aetna, Cigna, UnitedHealthcare) also commonly require PA for injectable testosterone. Approval turnaround ranges from 24 to 72 hours for standard requests. CareFirst, the largest insurer in Maryland covering approximately 3.4 million members, categorizes testosterone enanthate as a Tier 2 preferred generic on most formularies.

A 10 mL vial of testosterone enanthate 200 mg/mL (the most commonly prescribed concentration) costs between $40 and $90 at Maryland retail pharmacies without insurance. With insurance or a manufacturer coupon, out-of-pocket cost drops to $0 to $30 in most cases. Compounding pharmacies may offer alternative pricing structures, particularly for patients paying cash.

503A Compounding Pharmacies in Maryland

Maryland licenses 503A compounding pharmacies under the Maryland Board of Pharmacy. These pharmacies may compound testosterone enanthate for individual patients with a valid prescription. They cannot distribute compounded products without patient-specific prescriptions, which distinguishes them from 503B outsourcing facilities that produce larger batches.

Compounded testosterone enanthate from a 503A pharmacy may use different carrier oils (grapeseed oil or sesame oil, for example) than commercially manufactured products, which can matter for patients with specific allergies. Dr. Abraham Morgentaler, Associate Clinical Professor of Urology at Harvard Medical School, has noted: "The choice between commercial and compounded testosterone often comes down to individual tolerance, carrier oil preference, and cost considerations rather than efficacy differences" [5].

Maryland 503A pharmacies can ship within the state. Some telehealth platforms partner directly with licensed Maryland compounding pharmacies to simplify the prescription-to-delivery pipeline. Delivery typically takes 3 to 7 business days from the date the pharmacy receives the prescription.

Quality matters with compounding. The FDA's guidance on compounding distinguishes between 503A and 503B facilities, with 503B facilities subject to current Good Manufacturing Practice (cGMP) requirements [6]. Patients should verify that their compounding pharmacy holds current Maryland Board of Pharmacy accreditation and, ideally, voluntary PCAB (Pharmacy Compounding Accreditation Board) accreditation.

Transferring a Testosterone Enanthate Prescription to Maryland

Testosterone enanthate is a Schedule III controlled substance under both federal law and the Maryland Controlled Dangerous Substances Act. Maryland permits the transfer of controlled substance prescriptions between pharmacies, but specific rules apply.

A Schedule III prescription may be transferred one time between pharmacies. The transferring pharmacist must void the original prescription and record the receiving pharmacy's information. The receiving pharmacist must verify the prescription's validity, including the DEA number of the original prescriber.

If you are relocating to Maryland from another state, the more reliable path is to establish care with a Maryland-licensed provider. Bring your medical records, recent lab results, and a letter from your current provider summarizing your treatment history. Most Maryland TRT providers can see transfer patients within 1 to 2 weeks and continue your existing regimen without interruption if labs are current and stable.

For active-duty military and veterans, the Walter Reed National Military Medical Center in Bethesda and the VA Maryland Health Care System in Baltimore both maintain endocrinology departments that prescribe testosterone enanthate.

Dosing and Administration in Maryland Clinical Practice

The FDA-approved prescribing information for testosterone enanthate specifies a dose range of 50 to 400 mg every 2 to 4 weeks for male hypogonadism [7]. Current clinical practice, informed by pharmacokinetic data and the Endocrine Society's 2018 guideline, favors more frequent dosing at lower individual doses to minimize peak-trough fluctuations.

Most Maryland TRT clinicians prescribe 100 to 200 mg intramuscularly once weekly or 50 to 100 mg twice weekly. The twice-weekly protocol produces more stable serum testosterone levels and may reduce estradiol conversion and hematocrit elevation. A pharmacokinetic study by Snyder et al. demonstrated that weekly injections of testosterone enanthate produce peak serum levels approximately 2 to 5 days post-injection, with a half-life of approximately 4.5 days [4].

Subcutaneous injection of testosterone enanthate, while technically off-label, has gained clinical acceptance. A 2017 study published in the Journal of Clinical Endocrinology & Metabolism (N=232) found that subcutaneous testosterone injections achieved equivalent serum levels to intramuscular injections with fewer injection-site reactions [8]. Many Maryland providers now offer patients the choice between IM and subcutaneous routes.

Monitoring schedule after initiation:

• 6 to 8 weeks: first follow-up labs (total testosterone trough, hematocrit, PSA)
• 3 months: clinical symptom reassessment
• 6 months: comprehensive labs including lipid panel
• Annually thereafter: full panel plus DXA scan consideration for men over 50

Timeline: From Consultation to First Injection

The speed of access depends on whether you use an in-person provider or telehealth.

Telehealth pathway (fastest):

• Day 1: Complete intake, order labs
• Days 2 to 4: Lab draw at local facility
• Days 4 to 7: Video consultation after results return
• Days 7 to 10: Prescription sent to pharmacy, medication shipped
• Days 10 to 14: First injection (self-administered at home or at provider office)

In-person pathway:

• Week 1: Schedule and attend initial appointment
• Week 1 to 2: Lab draw (sometimes same day as consult)
• Week 2 to 3: Follow-up to review results
• Week 3 to 4: Prescription filled, first injection

The telehealth route compresses the timeline by 1 to 2 weeks in most cases. Some telehealth platforms pre-order lab panels before the consultation, which eliminates one waiting period entirely.

Maryland-Specific Legal Considerations

Maryland classifies anabolic steroids, including testosterone enanthate, as Schedule III controlled dangerous substances under Health-General Article § 5-101. Possession without a valid prescription is a criminal offense carrying penalties of up to 5 years imprisonment and a $15,000 fine for first offenses.

The Maryland Board of Physicians actively investigates "pill mill" prescribing patterns. Legitimate TRT prescribers document diagnostic criteria, monitor patients on a defined schedule, and adjust doses based on lab results. The AUA (American Urological Association) guideline on testosterone deficiency recommends against prescribing testosterone to men with a total testosterone level above 300 ng/dL unless free testosterone is also low and symptoms are present [9].

Maryland's Prescription Drug Monitoring Program (PDMP) tracks all Schedule II through V controlled substance prescriptions dispensed in the state. Prescribers must query the PDMP before writing a new testosterone prescription, and pharmacists report dispensing data within 24 hours.